Publications

Nederlands tijdschrift voor geneeskunde

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

15-11-2008

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

20-09-2008

The Lancet. Oncology

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

01-12-2007

Molecular biology of the cell

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

01-04-1996

British journal of cancer

Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.

01-02-1996

Biochemical Society transactions

Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas.

01-11-1995

The Journal of cell biology

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

01-04-1995

Cancer letters

Is episialin/MUC1 involved in breast cancer progression?

23-03-1995

The Journal of cell biology

The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.

01-12-1994